You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Ajax Therapeutics
since
auto-detected in 1 stories
27 hours ago
Eli Lilly said on Monday it would buy privately held blood cancer treatment developer Ajax Therapeutics for up to $2.3 billion in cash.
page 1 of 1